MedicaNatumin is a self-care group based in Habo and Jönköping, focusing on developing and marketing healthcare products based on innovative ingredients and solid research.

Our goal is to contribute to a positive health trend and to provide improved quality of life through products that treat or support the human body’s functions.

Among our product categories are dietary supplements, medical devices and dermatological and cosmetic products. Among the brands are leading dietary supplements like L-Argiplex and Nypozin and the scientifically documented skin care series Jabushe.

The foundation of MedicaNatumin’s business is to offer innovative products and strong brands from a sustainable and scientific base.
Our starting point is to have a strong position on the Nordic market while developing international partnerships and export operations.

We have all essential parts of the organisation; innovation and product development based on a strong patent platform, a local production that meets strict hygiene and quality requirements, a well-functioning sales and marketing department, and the entire organization is penetrated by clear roles and responsibilities.

Shares

Aktiestruktur

Antal aktier	375 989 277
Summa emitterat	375 989 277
Antal aktieägare	1 816 st
Antal teckningsoptioner	16 300 000 (1 option = 1 aktie)
ISIN	Aktie SE0001789793

Statistik

Först	0.483
Högst	0.483
Medel	0.459
Lägst	0.452
Senast	0.470
+/- Sek	-0.01
+/- %	-2.89
Omsättning	111776.732
Volym	243228
ISIN	SE0001789793

Aktieägare

Aktieägare	Antal aktier	Andel (ca)
N.P.H i Habo AB	75 000 000	19,95%
Försäkringsbolaget, Avanza Pension	38 418 365	10,22%
Swedbank Försäkring AB	38 232 691	10,17%
TJ Gruppen AB	18 660 142	4,96%
Jool Invest AB	17 448 434	4,64%
Lars-Olof Johansson	8 837 360	2,35%
Jesper Pettersson	8 660 000	2,30%
Jörgen Wehmonen	6 720 660	1,79%
Karl-Olov Eriksson	6 119 725	1,63%
Nordnet Pensionsförsäkring AB	5 053 765	1,34%
Summa	223 151 142	59,35%
Övriga 1 806 aktieägare	152 838 135	40,65%
Totalt antal aktier	375 989 277	100,00 %